Home » VENTIV HEALTH PROVIDES MEDICAL SCIENCE LIAISONS TO BRISTOL-MYERS SQUIBB
VENTIV HEALTH PROVIDES MEDICAL SCIENCE LIAISONS TO BRISTOL-MYERS SQUIBB
Ventiv Health, Inc., today announced that it has expanded its service relationship with Bristol-Myers Squibb Company and will be providing Medical Science Liaison assistance to Bristol-Myers Squibb for the anti-bacterial drug Tequin(R). Under the terms of the agreement Ventiv will provide a team of Medical Science Liaisons who will be responsible for educating a variety of audiences, including infectious disease specialists in hospital-based academic and managed care settings, on the latest clinical and scientific data associated with Tequin(R).
Finanzen.net (http://finanzen.net/news/news_detail.asp?NewsNr=335378)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May